| |
| |
|
| Insider
Information: |
Henderson Jeffrey William |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
161,643 |
|
|
Indirect Shares
|
15 |
|
|
| Direct
Value |
$11,678,183 |
|
|
|
Indirect Value
|
$3,480 |
|
|
| Total
Shares |
161,658 |
|
|
| Total
Value |
$11,681,663 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -36.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
Chief Financial Officer |
2014-08-27 |
67,190 |
2012-09-07 |
0 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
53,611 |
2015-08-05 |
0 |
Premium* |
|
|
QUALCOMM Inc |
QCOM |
Director |
2024-03-10 |
6,408 |
|
0 |
Premium* |
|
|
Fibrogen Inc |
FGEN |
Director |
2023-09-01 |
28,866 |
2018-06-05 |
0 |
Premium* |
|
|
Becton Dickinson & Co |
BDX |
Director |
2024-01-23 |
5,568 |
2024-01-23 |
15 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
Executive Vice President |
• – – |
2005-04-18 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
21,000 |
|
- |
|
| CAH |
Cardinal Health Inc |
EVP & Chief Financial Officer |
• – – |
2006-04-18 |
4 |
D |
$69.85 |
$4,331 |
D/D |
(62) |
20,938 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
6,405 |
6,405 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2016-01-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
74 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2016-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,202 |
26,607 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,135 |
40,742 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2018-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
795 |
869 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2018-03-22 |
4 |
D |
$55.58 |
$14,284 |
D/D |
(257) |
612 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2018-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
10,363 |
51,105 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2018-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,700 |
3,700 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2019-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
923 |
1,310 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2019-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,099 |
5,711 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2019-03-08 |
4 |
D |
$53.53 |
$88,003 |
D/D |
(1,644) |
4,067 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
63,278 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2019-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
8,400 |
0 |
- |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2020-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
765 |
2,089 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2020-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,644 |
8,711 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2020-03-10 |
4 |
D |
$78.89 |
$118,098 |
D/D |
(1,497) |
7,214 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
72,107 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2020-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
13,100 |
0 |
- |
|
| QCOM |
QUALCOMM Inc |
Director |
– • – |
2020-11-10 |
4 |
S |
$141.10 |
$846,602 |
D/D |
(6,000) |
1,214 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-11-25 |
4 |
S |
$40.08 |
$981,757 |
D/D |
(24,498) |
47,609 |
0 |
% |
|
| BDX |
Becton Dickinson & Co |
Director |
– • – |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
829 |
2,918 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
52,839 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
Director |
– • – |
2021-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,700 |
17,800 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
